Helping you help patients
Helping you manage patient outcomes with the educational resources, clinical data and product information you need, whenever you need them
Our commitment to patients with hemophilia and rare bleeding disorders is reflected in our broad therapy portfolio
Actor portrayal
Trial prescription programs
Get details on our trial prescription program.
Patient access and affordability
See savings and benefits verification options.
Clinical education library
Review materials on diagnosing, treating and managing patients.
Featured in professional education
Interactive Joint Bleed Model
Understanding the risks and realities of joint damage may improve patient adherence, but it can be difficult for patients to comprehend the long-term consequences of delaying treatment. Designed to teach patients about the progressive impact of joint bleeds over time, this short animated video also features interactive hotspots to highlight key information for you to share with your patients.
Understanding acquired hemophilia
Acquired hemophilia appears spontaneously in people who were not born with hemophilia. Learn the signs of this rare condition.
Actor portrayal
Detecting and managing patients with inhibitors
Controlling bleeds in patients with hemophilia with inhibitors is more challenging–early identification and careful management is important for patient health.1
Learning the signs of Glanzmann's thrombasthenia
Recognizing Glanzmann's thrombasthenia begins with learning the signs of this rare bleeding disorder.
Affordability resources for your patients
NovoCare® provides affordability and access support resources to help your patients obtain the medicine that’s right for them.
Actor portrayal
Actor portrayal
Reference:
- World Federation of Hemophilia. Guidelines for the management of hemophilia, 3rd edition. Haemophilia. 2020;26(Suppl 6):1–158.